Core Insights - The article discusses the financial positions and potential compensation of Parkev Tatevosian, CFA, in relation to stocks mentioned, indicating a lack of direct investment in those stocks [1] Company and Industry Summary - Parkev Tatevosian has no position in any of the stocks mentioned, which suggests an impartial analysis of the stocks [1] - The Motley Fool, as an organization, also has no position in the stocks mentioned, reinforcing the objectivity of the analysis [1] - There is a disclosure policy in place, indicating transparency regarding potential conflicts of interest related to stock promotions [1]

Core Points - As of January 31, 2025, EssilorLuxottica has 457,507,201 shares outstanding and 456,576,523 real voting rights, excluding treasury shares [2][3] - The theoretical number of voting rights, including treasury shares, remains the same at 457,507,201 [3] - Voting rights are capped at 31% for any shareholder, as per the company's by-laws [3] Company Information - EssilorLuxottica is recognized as the global leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses [2] - The company’s by-laws and additional information can be accessed on its official website [4]

Core Insights - EssilorLuxottica has acquired Cellview Imaging Inc, a Canadian med-tech start-up specializing in innovative retinal imaging technology, to enhance its portfolio in vision care [1][2] Group 1: Acquisition Details - The acquisition aims to elevate industry standards and improve the quality of vision care through advanced diagnostic tools [1] - Cellview's proprietary ultra-widefield retinal camera captures larger images, enabling better diagnosis of retinal pathologies [2] Group 2: Company Background - Cellview is based in Toronto and is known for its strong internal R&D capabilities, producing FDA and CE approved diagnostic imaging instruments [2] - The company's products are currently distributed in North America and are set to expand into Europe [2] Group 3: Strategic Goals - EssilorLuxottica's leadership expressed enthusiasm about integrating Cellview's expertise to accelerate their vision health strategy [3] - The integration is expected to provide a comprehensive portfolio of innovative technologies to the ophthalmic care community, addressing the growing need for early diagnosis of retinal conditions [3]

Core Insights - Estee Lauder's international operations are crucial for understanding its financial resilience and growth potential [1][2] - The company's reliance on foreign markets can provide protection against local economic downturns while also presenting challenges [3] Revenue Performance - Total revenue for the quarter was $4 billion, reflecting a decrease of 6.4% [4] - Revenue from Europe, the Middle East & Africa was $1.49 billion, accounting for 37.31%, slightly below the expected $1.5 billion [5] - Asia/Pacific contributed $1.29 billion, or 32.14%, exceeding the consensus estimate of $1.27 billion [6] Future Projections - Analysts predict Estee Lauder will generate $3.52 billion in revenue for the ongoing fiscal quarter, a decline of 10.6% year-over-year [7] - For the full year, total revenue is expected to be $14.61 billion, down 6.4% from the previous year, with Europe, the Middle East & Africa and Asia/Pacific expected to contribute $5.79 billion and $4.42 billion, respectively [8] Market Trends - Tracking international revenue trends is essential for projecting Estee Lauder's future trajectory [9] - Analysts are closely monitoring these trends due to increasing international interdependencies and geopolitical disputes [10] Stock Performance - Estee Lauder's stock has declined by 11.5% over the past month, contrasting with a 2.1% rise in the Zacks S&P 500 composite [12] - Over the past three months, the company's shares gained 2%, compared to a 1.2% increase in the S&P 500 [12]

Shares of makeup conglomerate Estee Lauder (EL -2.55%) plunged 23% through Thursday trading this week, according to data from S&P Global Market Intelligence.The company reported earnings on Tuesday, and while reported results actually beat expectations, they still showed declining revenue and profits. Moreover, management forecast continued declines for the March quarter.New CEO Stéphane de La Faverie also announced a shakeup of the business called "Beauty Reimagined." While a major restructuring may be war ...

If you enjoyed this, consider Ian's Insider Corner to enjoy access to similar initiation reports for all the new stocks that we buy. Membership also includes an active chat room, weekly updates, and my responses to your questions.Estée Lauder (NYSE: EL ) reported earnings on Tuesday, and the results set off a fresh wave of selling in the beaten-down stock. Shares had been attempting to rally around turnaround efforts and rumors of potentialIan leads the investing group Ian's Insider Corner . Features of the ...

Group 1 - Estee Lauder's shares have lost 50% of their value over the past year, primarily due to weak sales, particularly in China [1] - The stock experienced a significant decline of 16% on Tuesday, indicating ongoing struggles for the company [1]

CHONGQING, CHINA - JANUARY 18: Performers wearing elaborate traditional Chinese headdresses and ... [+] costumes participate in a cultural event at Jiefangbei on January 18, 2025 in Chongqing, China. (Photo by Cheng Xin/Getty Images)Getty ImagesEstée Lauder (NYSE: EL) recently released its Q2 fiscal 2025 results (fiscal ends in June), with revenues and earnings exceeding the street estimates. It reported sales of $4.0 billion and adjusted earnings of $0.62 per share, compared to the consensus estimates of $ ...

Consumer pullback around the world is leading Estée Lauder to cut thousands of jobs.The beauty brand released earnings Tuesday (Feb. 4) showing declining or flat sales in its markets around the globe, especially in Asia, where sales fell by double digits.Speaking to analysts during an earnings call, CEO Stéphane de La Faverie discussed some of the factors that have hurt the company’s performance in recent years, including “subdued” consumer sentiment in China and a “narrow focus” on too few markets.“This wa ...

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining around 0.6% on Tuesday.The Dow traded up 0.13% to 44,481.08 while the NASDAQ gained 1.18% to 19,620.50. The S&P 500 also rose, gaining, 0.58% to 6,029.54.Check This Out: Jim Cramer: AutoZone Is A ‘Great’ Stock, Recommends Buying This Energy StockLeading and Lagging SectorsEnergy shares surged by 1.9% on Monday.In trading on Monday, utilities shares fell by 0.9%.Top HeadlineU.S. factory orders fell by 0.9% from the previous month t ...